|
|
|
Insider
Information: |
Tang Capital Partners Lp |
Relationship: |
10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
123,746 |
|
Indirect Shares
|
35,438,120 |
|
|
Direct
Value |
$27,818 |
|
|
Indirect Value
|
$75,698,131 |
|
|
Total
Shares |
35,561,866 |
|
|
Total
Value |
$75,725,949 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
11
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-4.3%
|
-74.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-14 |
4 |
B |
$1.80 |
$67,039 |
I/I |
37,300 |
4,757,038 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-19 |
4 |
B |
$0.98 |
$1,058,478 |
I/I |
1,080,852 |
4,839,058 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-01-09 |
4 |
B |
$1.99 |
$2,023,403 |
I/I |
1,015,000 |
4,841,196 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2015-06-10 |
4 |
B |
$24.75 |
$2,999,997 |
I/I |
121,212 |
4,867,530 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-22 |
4 |
B |
$1.00 |
$99,880 |
I/I |
100,000 |
4,939,058 |
1.5 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-23 |
4 |
B |
$0.98 |
$78,520 |
I/I |
80,000 |
5,019,058 |
1.5 |
- |
|
JNCE |
Jounce Therapeutics Inc |
10% Owner |
|
2023-03-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,214,100 |
|
% |
|
JNCE |
Jounce Therapeutics Inc |
10% Owner |
|
2023-03-13 |
4 |
B |
$0.99 |
$65,307 |
I/I |
65,701 |
5,279,801 |
1.5 |
% |
|
JNCE |
Jounce Therapeutics Inc |
10% Owner |
|
2023-03-14 |
4 |
B |
$1.02 |
$20,651 |
I/I |
20,286 |
5,300,087 |
1.5 |
% |
|
ARDM |
Aradigm Corp |
10% Owner |
|
2008-10-10 |
4 |
B |
$0.24 |
$10,602 |
I/I |
45,000 |
5,355,000 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2008-09-30 |
4 |
B |
$0.97 |
$627,900 |
I/I |
650,000 |
5,355,693 |
1.5 |
- |
|
ARDM |
Aradigm Corp |
10% Owner |
|
2008-10-13 |
4 |
B |
$0.24 |
$6,000 |
I/I |
25,000 |
5,380,000 |
1.5 |
- |
|
ARDM |
Aradigm Corp |
10% Owner |
|
2008-10-20 |
4 |
B |
$0.24 |
$4,080 |
I/I |
17,000 |
5,397,000 |
1.42 |
- |
|
ARDM |
Aradigm Corp |
10% Owner |
|
2008-10-21 |
4 |
B |
$0.24 |
$2,400 |
I/I |
10,000 |
5,407,000 |
1.42 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-17 |
4 |
B |
$1.65 |
$1,096,652 |
I/I |
665,000 |
5,506,196 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-19 |
4 |
B |
$1.47 |
$66,258 |
I/I |
45,000 |
5,551,196 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-23 |
4 |
B |
$1.42 |
$34,238 |
I/I |
24,140 |
5,575,336 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-24 |
4 |
B |
$1.51 |
$1,967 |
I/I |
1,300 |
5,576,636 |
1.42 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2008-09-25 |
4 |
B |
$1.04 |
$622,680 |
I/I |
600,000 |
5,619,058 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-25 |
4 |
B |
$1.50 |
$103,572 |
I/I |
69,200 |
5,645,836 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-03-05 |
4 |
B |
$1.49 |
$126,761 |
I/I |
85,000 |
5,730,836 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2018-09-12 |
4 |
S |
$35.75 |
$96,346,250 |
I/I |
(2,695,000) |
5,830,215 |
0 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2016-06-16 |
4 |
D |
$18.47 |
$4,500,012 |
I/I |
(243,639) |
5,873,891 |
0 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-03-06 |
4 |
B |
$1.39 |
$437,307 |
I/I |
309,300 |
6,040,136 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2016-06-16 |
4 |
OE |
$3.60 |
$4,500,000 |
I/I |
1,250,000 |
6,117,530 |
0 |
- |
|
176 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|